Glucocorticoid-dependent stimulation of adiposity and appetite by a ghrelin mimetic in the rat.
OBJECTIVE
Chronic administration of GH secretagogues (GHSs) induces a state of positive energy balance in rodents by a GH-independent mechanism. Here we sought to determine to what extent the GHS effects to increase food intake and increase fat accumulation are glucocorticoid-dependent.


METHODS
The effects of twice-daily s.c. injections of GH-releasing peptide-6 (GHRP-6) (250 microg/kg) for 2 weeks on body weight, food intake and fat pad weight were determined in both adrenalectomised (ADX) rats (with or without basal corticosterone replacement) and adrenal-intact rats.


RESULTS
All GHS-injected rats had a significantly increased body weight at the end of 2 weeks of treatment compared with saline controls. However, increased fat accumulation was only seen in adrenal-intact rats, with a 15% increase in s.c. inguinal (P<0.05 vs saline controls) and 20% increase in visceral mesenteric (P<0.05) fat pad weights following GHS treatment. The increased body weight observed in ADX rats following GHS treatment was not due to increased fat mass or increased weight of other organs measured. Food intake was increased for up to 7 h following a single injection of GHRP-6 in both the adrenal-intact (P<0.01) and corticosterone-replacement groups (P<0.05). This stimulating effect on food intake was not observed at any time point in the ADX rats without corticosterone replacement.


CONCLUSIONS
These data suggest that GHS-induced body weight gain is glucocorticoid-independent. However, basal levels of glucocorticoids are permissive for the GHS-induced increase in food intake whilst activation of the hypothalamo-pituitary-adrenal axis appears to contribute to the GHS-induced accumulation of fat mass.
Tung
Y L
YL
Department of Physiology, University of Cambridge, Downing Street, Cambridge CB2 3EG, Cambridge, UK.
Hewson
A K
AK
Dickson
S L
SL
D000273:Adipose Tissue; D000315:Adrenalectomy; D000818:Animals; D001066:Appetite / Q000187:drug effects*; D001823:Body Composition / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects; D003345:Corticosterone / Q000008:administration & dosage; D004435:Eating / Q000187:drug effects; D005260:Female; D054439:Ghrelin; D005938:Glucocorticoids / Q000502:physiology*; D007700:Kinetics; D009842:Oligopeptides / Q000008:administration & dosage*; D036361:Peptide Hormones / Q000819:agonists*; D051381:Rats; D017208:Rats, Wistar
D054439:Ghrelin; D005938:Glucocorticoids; D009842:Oligopeptides; D036361:Peptide Hormones; C041048:growth hormone releasing hexapeptide; D003345:Corticosterone